Loading clinical trials...
Loading clinical trials...
A Phase I Clinical Study of the Safety and Performance of the Treovance Stent-Graft With Navitel Delivery System for Patients With Infrarenal Abdominal Aortic Aneurysms
Conditions
Interventions
Treovance Abdominal Aortic Stent-Graft with Navitel Delivery System
Locations
6
United States
University of Massachusetts
Worcester, Massachusetts, United States
Spectrum Health System
Grand Rapids, Michigan, United States
Carolinas Sanger Heart and Vascular
Charlotte, North Carolina, United States
East Carolina University
Greenville, North Carolina, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Sentara Heart Hospital
Norfolk, Virginia, United States
Start Date
June 1, 2011
Primary Completion Date
April 1, 2013
Completion Date
June 1, 2017
Last Updated
December 20, 2017
NCT07224230
NCT07184723
NCT06710938
NCT06884397
NCT04252573
NCT02477111
Lead Sponsor
Bolton Medical
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions